Details
Stereochemistry | ACHIRAL |
Molecular Formula | C17H20N4O2 |
Molecular Weight | 312.3663 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=N)C1=CC=C(OCCCOC2=CC=C(C=C2)C(N)=N)C=C1
InChI
InChIKey=WTFXJFJYEJZMFO-UHFFFAOYSA-N
InChI=1S/C17H20N4O2/c18-16(19)12-2-6-14(7-3-12)22-10-1-11-23-15-8-4-13(5-9-15)17(20)21/h2-9H,1,10-11H2,(H3,18,19)(H3,20,21)
Propamidine, an aromatic diamidine compound, is widely used as an antimicrobial agent. Propamidine isethionate, the salt of propamidine with isethionic acid, is used in the treatment of Acanthamoeba infection. Diseases caused by Acanthamoeba include keratitis and granulomatous amoebic encephalitis.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Treatment of experimental pneumocystosis: review of 7 years of experience and development of a new system for classifying antimicrobial drugs. | 1992 Sep |
|
New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii. | 1995 Nov 24 |
|
1,5-Bis(4-amidinophenoxy)pentane (pentamidine) is a potent inhibitor of [3H]idazoxan binding to imidazoline I2 binding sites. | 1998 Jul 17 |
|
Structure-in vitro activity relationships of pentamidine analogues and dication-substituted bis-benzimidazoles as new antifungal agents. | 1998 Oct |
|
Atypical presentation of Acanthamoeba keratitis. | 2001 Oct |
|
Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity. | 2003 Aug |
|
Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei. | 2003 Oct |
|
Are cataract and iris atrophy toxic complications of medical treatment of acanthamoeba keratitis? | 2004 Apr |
|
Methicillin-resistant Staphylococcus aureus clones, Western Australia. | 2006 Feb |
|
Antibacterial resistance and their genetic location in MRSA isolated in Kuwait hospitals, 1994-2004. | 2006 Nov 25 |
|
Bilateral acanthamoeba keratitis. | 2008 Feb |
|
Evaluation of Antioxidant and Wound Healing Effects of Alcoholic and Aqueous Extract of Ocimum sanctum Linn in Rats. | 2008 Mar |
|
Rapidly progressive cataract and iris atrophy during treatment of Acanthamoeba keratitis. | 2008 May |
|
Medical management approach to infectious keratitis. | 2008 May-Jun |
|
Medical treatment for combined Fusarium and Acanthamoeba keratitis. | 2009 Mar |
|
The dissemination of ST80-SCCmec-IV community-associated methicillin resistant Staphylococcus aureus clone in Kuwait hospitals. | 2010 Nov 4 |
|
A retrospective study of nine cases of Acanthamoeba keratitis. | 2010 Oct 21 |
|
First report of a mixed infection due to Acanthamoeba genotype T3 and Vahlkampfia in a cosmetic soft contact lens wearer in Iran. | 2010 Sep |
Patents
Sample Use Guides
1-2 drops in the affected eye 3-4 times daily, for not more than 1 week
Route of Administration:
Topical
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/8985640
There was compared the amoebicidal activity of the Brolene (propamidine isethionate, commercial product), propamidine isethionate and pentamidine isethionate (Pentam) in vitro against three different species of Acanthamoeba, and the drugs' corresponding biocompatibility with rabbit corneal epithelial and endothelial cell cultures. The results indicated that there were significant species differences in drug sensitivity. Propamidine (> 1,000 micrograms/ml) was clearly less effective than pentamidine (> 125 micrograms/ml) against A. castellanii, although equivalent potency (> 250 micrograms/ml) was observed against A. polyphaga. On the other hand, propamidine (> 31.25 micrograms/ml) was slightly more effective than pentamidine (> 62.5 micrograms/ml) against A. hatchetti.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C277
Created by
admin on Fri Dec 15 15:09:50 GMT 2023 , Edited by admin on Fri Dec 15 15:09:50 GMT 2023
|
||
|
WHO-ATC |
S01AX15
Created by
admin on Fri Dec 15 15:09:50 GMT 2023 , Edited by admin on Fri Dec 15 15:09:50 GMT 2023
|
||
|
WHO-VATC |
QS01AX15
Created by
admin on Fri Dec 15 15:09:50 GMT 2023 , Edited by admin on Fri Dec 15 15:09:50 GMT 2023
|
||
|
WHO-VATC |
QD08AC03
Created by
admin on Fri Dec 15 15:09:50 GMT 2023 , Edited by admin on Fri Dec 15 15:09:50 GMT 2023
|
||
|
WHO-ATC |
D08AC03
Created by
admin on Fri Dec 15 15:09:50 GMT 2023 , Edited by admin on Fri Dec 15 15:09:50 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
87462
Created by
admin on Fri Dec 15 15:09:50 GMT 2023 , Edited by admin on Fri Dec 15 15:09:50 GMT 2023
|
PRIMARY | |||
|
203-195-2
Created by
admin on Fri Dec 15 15:09:50 GMT 2023 , Edited by admin on Fri Dec 15 15:09:50 GMT 2023
|
PRIMARY | |||
|
100000081130
Created by
admin on Fri Dec 15 15:09:50 GMT 2023 , Edited by admin on Fri Dec 15 15:09:50 GMT 2023
|
PRIMARY | |||
|
SUB10095MIG
Created by
admin on Fri Dec 15 15:09:50 GMT 2023 , Edited by admin on Fri Dec 15 15:09:50 GMT 2023
|
PRIMARY | |||
|
3493
Created by
admin on Fri Dec 15 15:09:50 GMT 2023 , Edited by admin on Fri Dec 15 15:09:50 GMT 2023
|
PRIMARY | |||
|
4182
Created by
admin on Fri Dec 15 15:09:50 GMT 2023 , Edited by admin on Fri Dec 15 15:09:50 GMT 2023
|
PRIMARY | |||
|
DTXSID6048674
Created by
admin on Fri Dec 15 15:09:50 GMT 2023 , Edited by admin on Fri Dec 15 15:09:50 GMT 2023
|
PRIMARY | |||
|
64949
Created by
admin on Fri Dec 15 15:09:50 GMT 2023 , Edited by admin on Fri Dec 15 15:09:50 GMT 2023
|
PRIMARY | |||
|
PROPAMIDINE
Created by
admin on Fri Dec 15 15:09:50 GMT 2023 , Edited by admin on Fri Dec 15 15:09:50 GMT 2023
|
PRIMARY | |||
|
34633
Created by
admin on Fri Dec 15 15:09:50 GMT 2023 , Edited by admin on Fri Dec 15 15:09:50 GMT 2023
|
PRIMARY | RxNorm | ||
|
104-32-5
Created by
admin on Fri Dec 15 15:09:50 GMT 2023 , Edited by admin on Fri Dec 15 15:09:50 GMT 2023
|
PRIMARY | |||
|
C005555
Created by
admin on Fri Dec 15 15:09:50 GMT 2023 , Edited by admin on Fri Dec 15 15:09:50 GMT 2023
|
PRIMARY | |||
|
propamidine
Created by
admin on Fri Dec 15 15:09:50 GMT 2023 , Edited by admin on Fri Dec 15 15:09:50 GMT 2023
|
PRIMARY | |||
|
CHEMBL23013
Created by
admin on Fri Dec 15 15:09:50 GMT 2023 , Edited by admin on Fri Dec 15 15:09:50 GMT 2023
|
PRIMARY | |||
|
C82250
Created by
admin on Fri Dec 15 15:09:50 GMT 2023 , Edited by admin on Fri Dec 15 15:09:50 GMT 2023
|
PRIMARY | |||
|
G20G12V769
Created by
admin on Fri Dec 15 15:09:50 GMT 2023 , Edited by admin on Fri Dec 15 15:09:50 GMT 2023
|
PRIMARY | |||
|
m9181
Created by
admin on Fri Dec 15 15:09:50 GMT 2023 , Edited by admin on Fri Dec 15 15:09:50 GMT 2023
|
PRIMARY | Merck Index | ||
|
DB13296
Created by
admin on Fri Dec 15 15:09:50 GMT 2023 , Edited by admin on Fri Dec 15 15:09:50 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)